India Glycols (INDIAGLYCO)₹308.35−2.39%Breweries & Distilleries
In the Jun 2026 quarter (consolidated), India Glycols reported sales of ₹1,128 Cr, up 8.6% from Jun 2025, and net profit of ₹96.92 Cr, up 32.9% year on year. For the year to Mar 2026, sales were ₹4,204 Cr and net profit ₹292 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 774 | 903 | 925 | 968 | 960 | 973 | 862 | 1,038 | 1,091 | 1,100 | 974 | 1,128 |
| Expenses | 680 | 803 | 823 | 844 | 846 | 852 | 718 | 892 | 936 | 928 | 812 | 962 |
| Operating Profit | 96.09 | 102 | 105 | 126 | 116 | 124 | 146 | 150 | 158 | 175 | 166 | 170 |
| OPM % | 12.0% | 11.0% | 11.0% | 13.0% | 12.0% | 13.0% | 17.0% | 14.0% | 14.0% | 16.0% | 17.0% | 15.0% |
| Other Income | 11.99 | 8.99 | 9.99 | 13.99 | 14.97 | 18.99 | 12.98 | 19.97 | 13.98 | 2.99 | 13.99 | 20.97 |
| Interest | 29.02 | 31.02 | 33.05 | 36.04 | 40.07 | 44.03 | 45.02 | 45.04 | 49.04 | 47.04 | 26.02 | 25.03 |
| Depreciation | 27.99 | 25.98 | 25.97 | 27.96 | 27.98 | 26.97 | 32.96 | 33.95 | 37.97 | 40.98 | 40.97 | 41.94 |
| Profit before tax | 50.16 | 54.22 | 56.15 | 76.28 | 63.19 | 71.19 | 82.26 | 91.33 | 84.29 | 91.26 | 112 | 123 |
| Tax % | 23.9% | 22.9% | 23.9% | 19.9% | 22.0% | 19.9% | 21.9% | 18.9% | 21.9% | 24.9% | 22.9% | 20.9% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.99 | 0.00 | 0.00 |
| Net Profit | 37.91 | 41.94 | 41.92 | 59.96 | 49.96 | 56.90 | 63.89 | 72.94 | 64.91 | 67.89 | 86.82 | 96.92 |
| EPS (Rs) | 6.15 | 6.74 | 6.83 | 9.76 | 8.04 | 9.19 | 10.35 | 11.84 | 10.52 | 10.10 | 12.97 | 14.46 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,321 | 2,496 | 3,030 | 3,350 | 2,733 | 2,312 | 2,862 | 2,647 | 3,289 | 3,762 | 4,204 | 4,293 |
| Expenses | 2,151 | 2,265 | 2,716 | 2,942 | 2,437 | 2,030 | 2,601 | 2,348 | 2,884 | 3,263 | 3,569 | 3,638 |
| Operating Profit | 175 | 237 | 322 | 417 | 304 | 291 | 270 | 305 | 415 | 511 | 650 | 670 |
| OPM % | 8.0% | 9.0% | 11.0% | 12.0% | 11.0% | 13.0% | 9.0% | 12.0% | 13.0% | 14.0% | 15.0% | 15.6% |
| Other Income | −46.96 | 6.99 | 22.97 | 16.97 | 23.97 | 14.99 | 260 | 53.97 | 29.98 | 60.93 | 49.98 | 51.93 |
| Interest | 139 | 127 | 125 | 143 | 97.11 | 83.11 | 70.11 | 100 | 121 | 164 | 167 | 147 |
| Depreciation | 68.98 | 71.97 | 72.89 | 75.89 | 77.89 | 79.98 | 79.96 | 93.96 | 101 | 115 | 155 | 162 |
| Profit before tax | −81.32 | 45.18 | 147 | 214 | 153 | 143 | 380 | 165 | 224 | 293 | 378 | 411 |
| Tax % | −30.1% | 21.9% | 33.9% | 37.9% | 24.9% | 8.0% | 9.9% | 14.9% | 22.9% | 20.9% | 21.9% | — |
| Exceptional items | −57.85 | 0.00 | 0.00 | 0.00 | −15.96 | −21.92 | 175 | 16.95 | −5.98 | 0.99 | 0.99 | −0.99 |
| Net Profit | −56.94 | 34.94 | 96.84 | 133 | 115 | 132 | 340 | 141 | 173 | 231 | 292 | 317 |
| EPS (Rs) | −9.19 | 5.67 | 15.60 | 21.44 | 18.53 | 21.28 | 54.91 | 20.22 | 27.99 | 37.36 | 43.70 | 48.05 |
| Dividend payout % | 0.0% | 9.0% | 12.9% | 13.9% | 15.9% | 13.9% | 7.0% | 18.9% | 14.0% | 13.0% | 17.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 31.13 | 31.08 | 31.11 | 31.09 | 31.12 | 31.12 | 31.10 | 31.12 | 31.10 | 31.12 | 31.09 | 34.14 |
| Reserves | 266 | 686 | 720 | 813 | 931 | 1,002 | 1,137 | 1,760 | 1,868 | 2,018 | 2,224 | 2,897 |
| Borrowings | 2,267 | 1,235 | 1,094 | 833 | 1,000 | 999 | 1,137 | 1,047 | 1,112 | 1,348 | 1,892 | 1,692 |
| Other Liabilities | 596 | 1,673 | 1,653 | 1,750 | 1,826 | 2,060 | 1,823 | 1,801 | 1,854 | 2,229 | 2,039 | 1,909 |
| Total Liabilities | 3,160 | 3,626 | 3,497 | 3,427 | 3,788 | 4,092 | 4,126 | 4,638 | 4,865 | 5,626 | 6,184 | 6,532 |
| Fixed Assets | 1,147 | 2,030 | 2,113 | 2,159 | 2,173 | 2,228 | 2,193 | 2,317 | 2,716 | 3,206 | 3,829 | 4,558 |
| CWIP | 162 | 181 | 91.13 | 89.09 | 137 | 172 | 126 | 243 | 125 | 84.10 | 98.09 | 37.05 |
| Investments | 4.01 | 28.03 | 25.04 | 24.02 | 21.02 | 26.03 | 27.04 | 336 | 319 | 335 | 381 | 390 |
| Other Assets | 1,848 | 1,387 | 1,269 | 1,156 | 1,457 | 1,666 | 1,781 | 1,741 | 1,705 | 2,000 | 1,875 | 1,547 |
| Inventories | 487 | 516 | 518 | 448 | 648 | 682 | 610 | 693 | 755 | 1,106 | 1,172 | 891 |
| Trade receivables | 437 | 364 | 390 | 334 | 322 | 569 | 362 | 399 | 430 | 384 | 365 | 351 |
| Cash & equivalents | 163 | 38.16 | 29.08 | 59.21 | 116 | 92.32 | 98.31 | 102 | 113 | 139 | 77.23 | 50.17 |
| Total Assets | 3,160 | 3,626 | 3,497 | 3,427 | 3,788 | 4,092 | 4,126 | 4,638 | 4,865 | 5,626 | 6,184 | 6,532 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −171 | 1,232 | 302 | 503 | 147 | 343 | 137 | 116 | 326 | 439 | 362 | 770 |
| Cash from investing activity | 175 | −77.81 | −39.91 | −103 | −128 | −151 | −148 | 75.77 | −329 | −502 | −734 | −765 |
| Cash from financing activity | −3.99 | −1,165 | −263 | −398 | 2.99 | −215 | 10.98 | −189 | −0.99 | 89.82 | 353 | 22.93 |
| Net cash flow | 0.00 | −14.99 | −0.99 | 0.00 | 21.98 | −22.98 | 0.00 | 3.99 | −4.99 | 24.96 | −19.99 | 24.97 |
| Capex | 70.76 | 94.65 | 41.89 | 130 | 139 | 150 | 149 | 379 | 437 | 551 | 757 | 820 |
| Free cash flow | −52.98 | 1,135 | 260 | 372 | 8.99 | 193 | −10.99 | −264 | −109 | −103 | −391 | −46.93 |
| CFO / OP % | −136.0% | 705.0% | 127.0% | 156.0% | 37.0% | 127.0% | 53.0% | 51.0% | 123.0% | 108.0% | 75.0% | 122.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 62 | 57 | 57 | 40 | 35 | 76 | 57 | 51 | 59 | 43 | 35 | 30 |
| Inventory days | 110 | 129 | 130 | 88 | 125 | 147 | 167 | 149 | 210 | 225 | 210 | 140 |
| Days payable | 55 | 120 | 144 | 152 | 143 | 155 | 158 | 137 | 209 | 222 | 175 | 123 |
| Cash conversion cycle | 115 | 66 | 42 | −25 | 17 | 67 | 65 | 62 | 60 | 44 | 70 | 47 |
| Working capital days | −110 | −94 | −117 | −78 | −50 | −64 | −79 | −31 | −46 | −63 | −56 | −49 |
| ROCE % | 3.0% | 5.0% | 9.0% | 15.0% | 20.0% | 14.0% | 10.0% | 9.0% | 8.0% | 11.0% | 12.0% | 12.0% |
For the Jun 2026 quarter, India Glycols reported sales of ₹1,128 Cr, up 8.6% year on year and net profit of ₹96.92 Cr, up 32.9% year on year. The operating margin was 15.0%.
India Glycols' sales for the year to Mar 2026 were ₹4,204 Cr; over the last twelve months they were ₹4,293 Cr.
Net profit for the year to Mar 2026 was ₹292 Cr, and ₹317 Cr over the last twelve months. Earnings per share over the same trailing period were ₹48.05.
India Glycols reported borrowings of ₹1,692 Cr at Mar 2026, against cash and equivalents of ₹50.17 Cr.
Cash from operations was ₹770 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹46.93 Cr.